Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
1 clinical trials · Condition
◉ Watch Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Rollover Study of Lumacaftor in Combination With Ivacaftor in Subjects 12 Years and Older With Cystic Fibrosis (NCT01931839) | Vertex Pharmaceuticals Incorporated | 2013-10-01 |
Track Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation automatically
Every clearance here is in the API, with alerts when new ones post.